Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 129:
130. The compound of claim 125, wherein the compound is of formula (II-A-2):, , or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof,
wherein:
R2 is C1-C6 alkyl, OR2f, or C3-C8 cycloalkyl:
wherein the C1-C6 alkyl is optionally substituted by 1, 2, 3, or 4 independently selected R2a substituents; and
wherein the C3-C8 alkyl is optionally substituted by 1, 2, 3, or 4 independently selected R2b substituents; and

R2f is C1-C6 alkyl or C3-C8 cycloalkyl, wherein the C1-C6 alkyl or C3-C8 cycloalkyl is optionally substituted by 1, 2, 3, or 4 independently selected R2i substituents.